GoodRx(GDRX) - 2025 Q2 - Quarterly Results

Exhibit 99.1 GOODRX REPORTS SECOND QUARTER 2025 RESULTS Second Quarter 2025 Revenue and Adjusted EBITDA Margin in Line with Previous Guidance; Pharma Manufacturer Solutions Revenue Increased 32% Year-Over-Year SANTA MONICA, Calif. -- ( August 6, 2025 ) -- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights "I'm excited ab ...